Musk raises eyebrows with salute gesture at Trump rally
Billionaire Elon Musk sparked controversy Monday after making a gesture at an event celebrating US President Donald Trump's inauguration, with some calling it a "Nazi" or "fascist" movement.
Read more
Trump signs pardons for 1,500 Capitol rioters
US President Donald Trump signed pardons Monday for some 1,500 participants in the January 6, 2021 riot at the US Capitol by his supporters who attempted to overturn the 2020 election.
Read more
Trump promises new US 'golden age' with blitz of presidential orders
Donald Trump vowed a new "golden age" for America as he was sworn in for a historic second presidential term Monday, immediately signing a blizzard of orders that he said would restore glory to a nation in decline.
Read more
Rubio wins unanimous nod to be top US diplomat
The US Senate unanimously approved Marco Rubio as secretary of state on Monday, putting the fellow senator in the frontline of President Donald Trump's often confrontational diplomacy.
Read more
Trump says will sign pardons for Capitol rioters
US President Donald Trump said he plans to sign pardons on Monday for participants in the January 6, 2021 riot at the US Capitol by his supporters who attempted to overturn the 2020 election.
Read more
The Now Corporation (OTC: NWPN) Sees Opportunities for Community Solar Projects in California
PASADENA, CA / ACCESS Newswire / January 21, 2025 / The Now Corporation (OTC PINK:NWPN), an emerging leader in solar energy and utility solutions, announces its strategic focus on expanding into the California community solar market. This opportunity arises as California introduces new legislation, Assembly Bill 2316, designed to incentivize community solar projects that integrate advanced battery storage technologies.
Read more
BioNxt Accelerates R&D with Move to Gen-Plus Laboratory in Munich, Germany, Expanding Drug Delivery Research Capabilities
VANCOUVER, BC / ACCESS Newswire / January 21, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, is excited to announce a major milestone in its research and development journey. The company is transitioning its cutting-edge R&D activities to the Gen-Plus Contract Research and Development Organization (CRDO) in Munich, Germany, with operations scheduled to begin on March 1, 2025. This move underscores BioNxt's commitment to scientific innovation and advancing solutions for unmet medical needs.
Read more
Rubio on track to take office quickly as US secretary of state
A Senate committee on Monday fast-tracked Marco Rubio's nomination to be US secretary of state, paving the way for him to take over quickly as top diplomat under President Donald Trump.
Read more
Chelsea beat Wolves to return to Premier League top four
Chelsea overcame a howler from goalkeeper Robert Sanchez to beat relegation-threatened Wolves 3-1 on Monday, ending a five-game winless run to climb back into the Premier League's top four.
Read more
'Please let us in': Trump crackdown leaves migrants in tears
Margelis Tinoco broke down in tears after her asylum appointment was canceled as part of a sweeping immigration crackdown announced by US President Donald Trump on his first day in office.
Read moreIn The News
